Project Grant R01NR020607

Award Date 6/12/24
Completion Date 3/31/29
Dollars Obligated $1.4M
Federal Grant Program
93.361
Assistance Type
Project Grant
Place of Performance
Indianapolis, IN 46202, USA
Similar Awards
This five-year, $3,732,394 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a cluster randomized trial to evaluate the effectiveness of the Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP) intervention. The study aims to improve documentation of advance care planning discussions and hospice use among assisted living residents with Alzheimer's disease and related dementias. The University of South Florida will...
The National Institute on Aging (NIA) awarded a Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to the University of Oklahoma Health Sciences Center to examine end-of-life care for persons living with dementia (PLWD). The $2,303,477 grant will leverage data from the Dementia Care Study (D-CARE), a 4-site randomized clinical trial, to compare documentation of PLWD advance care preferences, overall end-of-life care quality, and healthcare utilization in the last 6 months...
This Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) under CFDA 93.433 will support research to describe preventive care adherence and identify challenges in providing comprehensive preventive care for adults with cerebral palsy (CP). The $160,000 award, effective September 1, 2024 through August 31, 2026, will utilize a mixed-methods approach to: 1) analyze healthcare claims data to describe adherence to recommended...
This $2,307,536 federal Project Grant, awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), will leverage a natural experiment to examine the effects of integrated palliative care on health service outcomes and disparities in Parkinson's disease and Lewy body dementia. The primary awardee, The Trustees of the University of Pennsylvania, will: Examine patterns of palliative domain care and disparities across U.S. Parkinson's specialty centers; and Test the effects of a...
This Project Grant award from the National Institute on Aging (NIA), under CFDA 93.866 Aging Research, provides $486,000 to Weill Medical College of Cornell University to adapt the Collaborative Care Model for use in the palliative care setting. The goal is to improve depression and anxiety care for older adults with serious illnesses such as cancer, heart failure, and chronic lung disease. The project will utilize a community engagement approach to develop the Collaborative Care Model for...
This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) supports a $400,000 randomized trial to evaluate the impact of a "whole person navigation" intervention for adults with multiple chronic conditions. The intervention combines predictive modeling to identify high-risk patients with a navigation strategy to help guide them in accessing social services and overcoming...
This $917,701 federal Project Grant award under the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a 5-year study conducted by Brigham & Women's Hospital to implement and evaluate an Acute Hospital Care at Home (AHCAH) pathway specifically for people living with dementia. The study aims to: 1) Evaluate the effect of a pre-enrollment AHCAH pathway on quality of life over 12 months for persons with moderate to severe dementia (Aim 1); and 2) Evaluate the...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $858,166 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a randomized trial of a targeted palliative care intervention for patients with metastatic breast cancer. The study aims to improve documentation of end-of-life care preferences, delivery of end-of-life care, and participant-reported outcomes for this patient population....
This $195,480 Project Grant, awarded by the National Institute on Aging under CFDA Program 93.866 Aging Research, will fund the development and pilot testing of a culturally sensitive care management checklist to guide hospice transitions for Black, Latino, and Asian persons living with advanced dementia who receive home healthcare services. The project, titled "ENGAGE-D: Designing Culturally Sensitive Care Management for Hospice Transitions for Diverse Persons Living with Advanced...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $231,000.00 to the University of Rochester to develop and assess culturally-tailored approaches for improving equity in neurology palliative care research for Parkinson's disease, Lewy body dementia, and related disorders in Black and Hispanic communities. The project aims to: 1)...

MAPPING THE COMPLEX PROCESSES AND OUTCOMES OF CARE PLANNING - PROJECT SUMMARY/ABSTRACT ADVANCE CARE PLANNING (ACP) SUPPORTS PATIENTS IN IDENTIFYING AND COMMUNICATING THEIR PREFERENCES FOR MEDICAL CARE AND IS A KEY COMPONENT OF PATIENT-CENTERED CARE. THE PATIENT SELF DETERMINATION ACT OF 1990 NARROWLY DEFINED ACP AS DOCUMENTATION OF PREFERENCES FOR END-OF-LIFE PROCEDURES (E.G., RESUSCITATION), RESULTING IN A FOCUS ON ADVANCE DIRECTIVE COMPLETION. SINCE THEN, ACP HAS EVOLVED TO INCLUDE A FOCUS ON PREPARING PATIENTS AND CAREGIVERS FOR COMMUNICATION AND DECISION-MAKING ACROSS THE ILLNESS TRAJECTORY, WHICH IS BETTER CONCEPTUALIZED AS "CARE PLANNING" (CP) BECAUSE THE PROCESS INCLUDES BOTH ADVANCE AND IN-THE-MOMENT DECISIONS OVER THE LIFE COURSE. WHILE HEALTH SYSTEMS HAVE INVESTED IN CP AS A REQUISITE COMPONENT OF PATIENT- CENTERED CARE AND IT IS REIMBURSED BY THE CENTERS FOR MEDICARE AND MEDICAID SERVICES, WIDE HETEROGENEITY OF CP IMPLEMENTATION AND MEASUREMENT REMAIN, AND THE PERSPECTIVES AND NEEDS OF CULTURALLY DIVERSE PATIENTS, CAREGIVERS, AND INTERDISCIPLINARY KEY INFORMANTS (E.G., NURSES, ATTORNEYS, CHAPLAINS, ETC.,) HAVE NOT BEEN CONSIDERED. UNPRECEDENTED BASIC SCIENCE (NIH STAGE MODEL, STAGE 0) IS REQUIRED TO MAP THE COMPLEXITY OF THE ENTIRE CP PROCESS. IMPLEMENTATION SCIENCE AND HUMAN FACTORS ENGINEERING OFFER A PATH TOWARDS CLARITY. THIS PROPOSAL ADVANCES THE FIELD OF CP AND IMPLEMENTATION SCIENCE BY LEVERAGING DIVERSE KEY INFORMANT PERSPECTIVES AND HUMAN FACTORS ENGINEERING METHODS TO MAP IMPLEMENTATION PROCESSES OF CP AND TO IDENTIFY MEANINGFUL CP OUTCOMES ACROSS CLINICAL AND COMMUNITY SETTINGS AND ILLNESS TRAJECTORIES. WE WILL APPLY THE WELL- VALIDATED CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH (CFIR) MODEL TO ILLUMINATE CP'S COMPLEXITY. CFIR DOMAINS INCLUDE CP INNOVATION CHARACTERISTICS (E.G., DISCUSSIONS) THAT OPERATE IN AN INNER SETTING (E.G., INPATIENT, OUTPATIENT, NURSING HOME, HOSPICE) AND OUTER SETTING (E.G., POLICY, FAITH COMMUNITIES) CENTERED AROUND CULTURALLY AND ETHNICALLY DIVERSE INTERDISCIPLINARY KEY INFORMANTS (E.G., PATIENTS, CAREGIVERS, HEALTHCARE PROFESSIONALS, COMMUNITY LEADERS, LEGAL/POLICY EXPERTS) INVOLVING A RANGE OF IMPLEMENTATION COMPONENTS (E.G., INITIATING, FACILITATING, DOCUMENTING, STORING, ACCESSING, UPDATING CP WISHES). THIS COMPLEXITY IS AMPLIFIED BY PATIENTS' ILLNESS TRAJECTORIES, HEALTHCARE ACCESS, AND UNIQUE AND DIFFERING CULTURAL BACKGROUNDS. OUR STUDY AIMS ARE TO: 1) DEFINE PROCESSES OF CP FOR VARYING SETTINGS (COMMUNITY, OUTPATIENT, ACUTE CARE, LONG-TERM CARE, HOSPICE), ILLNESS TRAJECTORIES (HEALTHY/CHRONIC ILLNESS, SERIOUS ILLNESS, END-OF-LIFE), AND HEALTHCARE ACCESS (RURAL, PUBLIC, UNDER-RESOURCED) BY CREATING CP WORKFLOW ARCHETYPES; AND 2) IDENTIFY PATIENT/CAREGIVER CENTERED AND IMPLEMENTATION OUTCOMES FOR EACH COMPONENT OF THE CP WORKFLOW ARCHETYPES. USING CFIR AND HUMAN FACTORS ENGINEERING WE WILL MAP ESSENTIAL IMPLEMENTATION FACTORS OF CP THROUGH FOCUS GROUPS AND INTERVIEWS AND USE DELPHI METHODS TO IDENTIFY MEANINGFUL PATIENT/CAREGIVER CENTERED OUTCOMES AND IMPLEMENTATION OUTCOMES. OUR LONG-TERM GOAL IS TO SET THE DIRECTION FOR FUTURE CP POLICY, RESEARCH, AND IMPLEMENTATION AND TO DECREASE HEALTH DISPARITIES IN CP AND MEDICAL CARE DURING SERIOUS ILLNESS AND AT THE END OF LIFE.

Posted 6/12/24, 12:00 AM